Organ procurement and transplantation during the COVID-19 pandemic

Type Journal Article Author Alexandre Loupy Author Olivier Aubert Author Peter P. Reese Author Olivier Bastien Author Florian Bayer Author Christian Jacquelinet URL https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31040-0/abstract Series The Lancet Correspondence Volume 395 Issue 10237 Pages e95-e96 Publication The Lancet ISSN 0140-6736, 1474-547X Date 11/05/2020 Extra Publisher: Elsevier PMID: 32407668 Journal Abbr The Lancet DOI 10.1016/S0140-6736(20)31040-0 Accessed 2020-06-30 22:27:14 Library Catalog www.thelancet.com Language English Abstract End-stage organ failure is estimated to affect more than six million people worldwide.1 In 2018, transplant systems across the world enabled around 150 000 patients to benefit from a kidney, heart, lung, liver, or other solid organ—a number far less than the demand. According to data from WHO, more than 1 500 000 people live with a transplanted organ worldwide. In the USA, approximately 40 000 patients receive an organ transplant every year, but 120 000 patients remain on a waiting list for transplantation, with 7600 individuals dying annually while waiting for an organ transplant.